Leadership Overview
Moderna has 10 executives leading key functions including strategy, finance, marketing, operations, and legal.
Driven by a commitment to human health, Moderna pioneers mRNA medicine, transforming disease prevention and treatment across infectious diseases, cancer, rare disorders, and autoimmune conditions through scientific innovation and advanced technology.
Driven by a commitment to human health, Moderna pioneers mRNA medicine, transforming disease prevention and treatment across infectious diseases, cancer, rare disorders, and autoimmune conditions through scientific innovation and advanced technology.
Leadership Roles at Moderna
Stéphane Bancel - Chief Executive Officer
Stéphane Bancel, the Chief Executive Officer at Moderna, directs the company's overarching strategy and vision, guiding its pioneering work in mRNA medicine. Bancel drives the transformation of disease prevention and treatment across infectious conditions, cancer, rare disorders, and autoimmune challenges by blending scientific innovation with advanced technology. Overseeing global operations, the Chief Executive Officer ensures Moderna's commitment to developing mRNA-based medicines that deliver meaningful and lasting impact on human health. This leadership role involves fostering a distinctive culture and empowering a global team dedicated to advancing the company's mission. By championing cutting-edge research and development, Stéphane Bancel secures Moderna's position at the forefront of biotechnology, ensuring continued progress in addressing critical unmet medical needs worldwide.
Jamey Mock - Chief Financial Officer
Jamey Mock, the Chief Financial Officer at Moderna, manages all financial operations and strategic financial planning for the company. Mock oversees capital allocation, investor relations, and financial risk management, ensuring robust fiscal health as Moderna pioneers mRNA medicine. This executive drives financial strategies that support the development and delivery of innovative treatments and vaccines across infectious conditions, cancer, rare disorders, and autoimmune challenges. By optimizing financial resources, the Chief Financial Officer enables the company's global team to focus on advancing scientific innovation and technology. Jamey Mock's leadership ensures the financial stability required for Moderna to make a meaningful and lasting impact on human health, supporting long-term growth and operational excellence.
Sameh Ismail - Chief Marketing Officer & Senior Analyst
Sameh Ismail, the Chief Marketing Officer & Senior Analyst at Moderna, leads the strategic development and execution of marketing initiatives, analyzing market trends to inform product positioning. Ismail directs campaigns that communicate the transformative potential of mRNA medicine across infectious diseases, cancer, rare disorders, and autoimmune challenges. This role involves translating complex scientific advancements into accessible market strategies, ensuring broad understanding and adoption of Moderna's innovative treatments and vaccines. By integrating deep market analysis with creative marketing approaches, the Chief Marketing Officer & Senior Analyst enhances Moderna's global reach and impact. Sameh Ismail's dual focus on marketing leadership and analytical insight drives the company's mission to improve human health through cutting-edge biotechnology.
Sam Ismail - Chief Marketing Officer & Senior Analyst
Sam Ismail, the Chief Marketing Officer & Senior Analyst at Moderna, spearheads the strategic direction of marketing efforts, leveraging senior-level analysis to identify growth opportunities. Ismail directs the communication of Moderna's pioneering mRNA medicine capabilities, focusing on infectious conditions, cancer, rare disorders, and autoimmune challenges. This executive translates scientific breakthroughs into compelling market narratives, enhancing the company's brand presence and fostering patient engagement. By combining astute market analysis with impactful marketing strategies, the Chief Marketing Officer & Senior Analyst ensures that Moderna's innovative treatments and vaccines reach those who need them most. Sam Ismail's leadership reinforces the company's commitment to improving human health through advanced biotechnology and strategic market penetration.
Michael Aihe - Manager, Chief Marketing Officer Planning, Supply Chain
Michael Aihe, the Manager, Chief Marketing Officer Planning, Supply Chain at Moderna, orchestrates critical planning functions within the supply chain, directly supporting marketing objectives. Aihe ensures the efficient and effective delivery of Moderna's mRNA-based medicines, aligning supply chain operations with market demands for treatments and vaccines. This role is pivotal in managing the logistics and planning necessary to address infectious conditions, cancer, rare disorders, and autoimmune challenges globally. By optimizing supply chain processes, the Manager, Chief Marketing Officer Planning, Supply Chain facilitates the company's ability to scale production and distribution. Michael Aihe's contributions are essential to Moderna's mission of making a meaningful and lasting impact on human health through reliable access to innovative therapies.
Paula Rodríguez - Senior Chief Marketing Officer, Operations & Specialist
Paula Rodríguez, the Senior Chief Marketing Officer, Operations & Specialist at Moderna, drives operational excellence within marketing functions and provides specialized expertise. Rodríguez oversees key operational aspects that enhance the effectiveness of marketing strategies for Moderna's mRNA medicine portfolio. This executive focuses on streamlining processes and implementing best practices to support the company's efforts in infectious conditions, cancer, rare disorders, and autoimmune challenges. By ensuring seamless operational execution, the Senior Chief Marketing Officer, Operations & Specialist contributes to the successful delivery of innovative treatments and vaccines. Paula Rodríguez's specialized operational leadership reinforces Moderna's commitment to improving human health and expanding its global impact through efficient and strategic marketing.
Michelle Patel - Chief of Staff, Oncology
Michelle Patel, the Chief of Staff, Oncology at Moderna, provides strategic support and operational leadership within the company's oncology division. Patel works closely with oncology leadership to advance the development and commercialization of mRNA-based cancer therapies. This role involves coordinating cross-functional initiatives and ensuring alignment with the company's broader mission to transform disease treatment. By facilitating communication and driving key projects, the Chief of Staff, Oncology enhances the efficiency and impact of Moderna's oncology efforts. Michelle Patel's dedicated focus on oncology operations contributes significantly to Moderna's goal of making a lasting impact on human health through targeted and innovative medical solutions.
Jeffrey Salling - Chief of Staff & Operations Senior Director, Legal
Jeffrey Salling, the Chief of Staff & Operations Senior Director, Legal at Moderna, directs operational strategies and provides high-level support within the legal department. Salling ensures the efficient functioning of legal operations, supporting Moderna's pioneering work in mRNA medicine and its expansion into new therapeutic areas. This executive manages critical operational workflows that uphold the company's compliance and governance standards across its global initiatives. By optimizing legal department processes, the Chief of Staff & Operations Senior Director, Legal enhances the company's ability to navigate complex regulatory landscapes. Jeffrey Salling's leadership is integral to Moderna's mission of improving human health by ensuring robust legal and operational frameworks support scientific innovation.
Explore Leadership Teams in Manufacturing
Amneal Pharmaceuticals, Inc. (NASDAQ: AMRX) is a fully integrated global essential medicines company powered by a robust U.S. generics business and a growing branded business as well as deepening portfolios in institutional injectables, biosimilars and select international markets. Together, were rapidly becoming one of the most dynamic, purpose-driven pharmaceutical companies delivering more affordable access to essential medicines. Today, Amneal is much more than generics. A series of strategic investments over the years has bolstered our world-class scientific rigor, production capabilities and commercial infrastructure. We have also invested substantially in our people through leadership development and employee well-being programs. Together, these advancements have accelerated our ability to deliver innovation, more complex products and broadened portfolios in new categories and geographies. Two decades after our founding, Amneal is better positioned than ever to deliver outcomes that meet important medical needs, make quality medicines more accessible and more affordable, and provide solutions for tomorrows health challenges. We are Amneal and We make healthy possible.
Company Leadership
AC
Akums, headquartered in Delhi, India, is an international WHO-GMP certified integrated pharmaceutical manufacturing company.
Company Leadership TK
AS
Gufic Group is a respected player in the pharmaceutical industry, established in 1970, known for its innovative and high-quality pharmaceutical and herbal products, along with a diverse range of APIs. They are recognized as one of India's largest manufacturers of lyophilized injections, offering a variety of products including antibiotics, antifungals, and antiviral treatments. Their extensive network facilitates the supply of these products to major hospital chains and leading medical facilities across India. Gufic is committed to research and development, continuously launching advanced new products while expanding their international footprint.
Company Leadership NY
RK
RA
DR
Avara Pharmaceutical Services is a manufacturing organization. It offers aseptic liquid filling, sterile pharmaceutical, oral solid dose, packaging solutions and sterile injectables. The company was founded in 2015 and is located in Norman, Oklahoma.
Company Leadership AA
RM
RR
Frequently Asked Questions Regarding Moderna Top Executives and Leadership Team
